Core Viewpoint - QIAGEN N.V. plans to return approximately $500 million to shareholders through a synthetic share repurchase, which includes a direct capital repayment and a reverse stock split [1] Group 1 - The synthetic share repurchase is part of QIAGEN's strategy to enhance shareholder value [1] - Since the beginning of 2024, QIAGEN has returned about $650 million to shareholders through similar synthetic methods [1] - The announcement of the repurchase plan was made in November 2025 [1]